Warning: Invalid argument supplied for foreach() in /home/globaldi/public_html/modules/mod_banners/tmpl/default.php on line 9
 

Could thyroid dysfunction influence outcome in sunitinib-treated metastatic ... - UroToday PDF Print
UroToday
Sunitinib is a standard of care for metastatic renal cell carcinoma (mRCC). Hypothyroidism is frequently observed under sunitinib therapy. This study was conducted to prospectively determine the correlation between thyroid function and progression-free

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.